CheckImmune GmbH

CheckImmune is an innovative immune biomarker CRO for pre-clinical and clinical programs with direct access to fresh clinical material from patients. As a spin-off company of Charité Universitätsmedizin Berlin we have strong links to academic state-of-the art research. CheckImmune is providing biomarker studies with focus on novel immunotherapeutics (small molecules, biologics, Advanced Therapy Medicinal Products – ATMPs) and immunological challenges in other medical areas. CheckImmune is specialized in the development and validation of immunological biomarkers for global clinical trials and accredited according to ISO 17025 and 15189 with fulfilling the requirements of GCLP (Good Clinical Laboratory Practice).

Our core expertise includes assay development and validation for Receptor Occupancy, Flow Cytometry, Multiplex Cytokine Analyses, Functional Tests, Single Cell Multiomics, and Tissue Biopsies. We are a certified service provider for 10x Genomics, Olink, and ProteinSimple Ella.

We are a team of well recognized experts for immune biomarker analyses and data interpretation.

Our Services are Selection/validation of drug lead candidates, phase 0 studies with access to fresh patient material, therapy monitoring (safety, efficacy/stratification) and data analysis and scientific & medical interpretation. At CheckImmune, we develop highly specialized immunological biomarker assays and provide end-to-end lab services for clinical and preclinical trials. From assay design to regulatory-grade data analysis - we help biopharma companies understand immune responses with precision.

With a track record of more than 90 industry-sponsored trials and 120,000 samples we have earned an excellent international reputation.